SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 103 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $117,000 | -23.5% | 35,790 | +4.5% | 0.00% | – |
| Q3 2021 | $153,000 | -23.1% | 34,245 | -6.3% | 0.00% | – |
| Q2 2021 | $199,000 | -6.1% | 36,533 | +28.6% | 0.00% | – |
| Q1 2021 | $212,000 | -25.1% | 28,405 | +8.9% | 0.00% | – |
| Q4 2020 | $283,000 | +26.9% | 26,079 | +3.2% | 0.00% | – |
| Q3 2020 | $223,000 | -16.2% | 25,262 | 0.0% | 0.00% | – |
| Q2 2020 | $266,000 | +94.2% | 25,262 | +9.1% | 0.00% | – |
| Q1 2020 | $137,000 | -8.1% | 23,165 | +7.6% | 0.00% | – |
| Q4 2019 | $149,000 | -36.9% | 21,535 | -4.8% | 0.00% | – |
| Q3 2019 | $236,000 | +7.8% | 22,623 | -4.4% | 0.00% | – |
| Q2 2019 | $219,000 | +135.5% | 23,663 | +132.2% | 0.00% | – |
| Q1 2019 | $93,000 | -24.4% | 10,190 | -1.7% | 0.00% | – |
| Q3 2018 | $123,000 | -40.9% | 10,362 | -49.3% | 0.00% | – |
| Q2 2018 | $208,000 | +23.8% | 20,432 | +58.1% | 0.00% | – |
| Q1 2018 | $168,000 | +425.0% | 12,922 | +299.9% | 0.00% | – |
| Q4 2017 | $32,000 | -68.3% | 3,231 | -52.9% | 0.00% | – |
| Q3 2017 | $101,000 | -40.6% | 6,867 | -35.0% | 0.00% | – |
| Q2 2017 | $170,000 | +16900.0% | 10,559 | +11253.8% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 93 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 93 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |